Literature DB >> 33509338

Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018.

Lore Merdrignac1, Fatima Aït El Belghiti2, Elisabetta Pandolfi3, Mireia Jané4, Jane Murphy5, Kateřina Fabiánová6, Manuel García Cenoz7, Elmira Flem8, Sophie Guillot9, Alberto E Tozzi10, Gloria Carmona4, Adele Habington11, Jana Zavadilová6, Ana Navasués12, Håkon Bøås8, Daniel Lévy-Brühl2, Beatrice Ferretti3, Miguel Lanaspa13, Niam O'Sullivan11, Pavla Křížová6, Leticia Fernandino7, Terese Bekkevold8, Thomas Hanslik14, Carmen Muñoz-Almagro13,15,16, Sabrina Bacci17, Gianfranco Spiteri17, Marta Valenciano1, Alain Moren1.   

Abstract

IntroductionPERTINENT is a pilot active surveillance system of infants hospitalised with pertussis in six European Union/European Economic Area countries (37 hospitals, seven sites).AimThis observational study aimed to estimate annual pertussis incidence per site from 2016 to 2018 and respective trends between 2017 and 2018. Pertussis cases were described, including their severity.MethodsWe developed a generic protocol and laboratory guidelines to harmonise practices across sites. Cases were hospitalised infants testing positive for Bordetella pertussis by PCR or culture. Sites collected demographic, clinical, laboratory data, vaccination status, and risk/protective factors. We estimated sites' annual incidences by dividing case numbers by the catchment populations.ResultsFrom December 2015 to December 2018, we identified 469 cases (247 males; 53%). The median age, birthweight and gestational age were 2.5 months (range: 0-11.6; interquartile range (IQR): 2.5), 3,280 g (range: 700-4,925; IQR: 720) and 39 weeks (range: 25-42; IQR: 2), respectively. Thirty cases (6%) had atypical presentation either with cough or cyanosis only or with absence of pertussis-like symptoms. Of 330 cases with information, 83 (25%) were admitted to intensive care units including five deceased infants too young to be vaccinated. Incidence rate ratios between 2018 and 2017 were 1.43 in Czech Republic (p = 0.468), 0.25 in Catalonia (p = 0.002), 0.71 in France (p = 0.034), 0.14 in Ireland (p = 0.002), 0.63 in Italy (p = 0.053), 0.21 in Navarra (p = 0.148) and zero in Norway.ConclusionsIncidence appeared to decrease between 2017 and 2018 in all but one site. Enhanced surveillance of hospitalised pertussis in Europe is essential to monitor pertussis epidemiology and disease burden.

Entities:  

Keywords:  active surveillance; hospital surveillance; pertussis; pertussis incidence

Mesh:

Substances:

Year:  2021        PMID: 33509338      PMCID: PMC7848786          DOI: 10.2807/1560-7917.ES.2021.26.4.1900762

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  19 in total

1.  Seasonal patterns in time series of pertussis.

Authors:  S C De Greeff; A L M Dekkers; P Teunis; J C Rahamat-Langendoen; F R Mooi; H E De Melker
Journal:  Epidemiol Infect       Date:  2009-03-30       Impact factor: 2.451

2.  Severe underestimation of pertussis related hospitalizations and deaths in the Netherlands: A capture-recapture analysis.

Authors:  N A T van der Maas; J Hoes; E A M Sanders; H E de Melker
Journal:  Vaccine       Date:  2017-06-23       Impact factor: 3.641

Review 3.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Monitoring the Impact of Vaccination on Pertussis in Infants Using an Active Hospital-based Pediatric Surveillance Network: Results from 17 Years' Experience, 1996-2012, France.

Authors:  Sarah Tubiana; Emmanuel Belchior; Sophie Guillot; Nicole Guiso; Daniel Lévy-Bruhl
Journal:  Pediatr Infect Dis J       Date:  2015-08       Impact factor: 2.129

5.  Severe and unrecognised: pertussis in UK infants.

Authors:  N S Crowcroft; R Booy; T Harrison; L Spicer; J Britto; Q Mok; P Heath; I Murdoch; M Zambon; R George; E Miller
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

6.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

7.  Time series modeling of pertussis incidence in China from 2004 to 2018 with a novel wavelet based SARIMA-NAR hybrid model.

Authors:  Yongbin Wang; Chunjie Xu; Zhende Wang; Shengkui Zhang; Ying Zhu; Juxiang Yuan
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

8.  Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999-2015.

Authors:  Bahaa Abu-Raya; Julie A Bettinger; Otto G Vanderkooi; Wendy Vaudry; Scott A Halperin; Manish Sadarangani
Journal:  J Pediatric Infect Dis Soc       Date:  2020-04-30       Impact factor: 3.164

9.  An update of the global burden of pertussis in children younger than 5 years: a modelling study.

Authors:  Karene Hoi Ting Yeung; Philippe Duclos; E Anthony S Nelson; Raymond Christiaan W Hutubessy
Journal:  Lancet Infect Dis       Date:  2017-06-13       Impact factor: 25.071

10.  Pertussis in infants: an underestimated disease.

Authors:  Anna Chiara Vittucci; Valentina Spuri Vennarucci; Annalisa Grandin; Cristina Russo; Laura Lancella; Albero Eugenio Tozzi; Andrea Bartuli; Alberto Villani
Journal:  BMC Infect Dis       Date:  2016-08-15       Impact factor: 3.090

View more
  3 in total

Review 1.  Experts' Opinion for Improving Pertussis Vaccination Rates in Adolescents and Adults: A Call to Action.

Authors:  Giovanni Gabutti; Irene Cetin; Michele Conversano; Claudio Costantino; Paolo Durando; Sandro Giuffrida
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

2.  Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020.

Authors:  Marion Debin; Titouan Launay; Louise Rossignol; Fatima Ait El Belghiti; Sylvain Brisse; Sophie Guillot; Nicole Guiso; Daniel Levy-Bruhl; Lore Merdrignac; Julie Toubiana; Thierry Blanchon; Thomas Hanslik
Journal:  Euro Surveill       Date:  2022-04

Review 3.  Can vaccines control bacterial virulence and pathogenicity? Bordetella pertussis: the advantage of fitness over virulence.

Authors:  Nicole Guiso; Benoit Soubeyrand; Denis Macina
Journal:  Evol Med Public Health       Date:  2022-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.